Company / Book Value per Share
CRISPR Therapeutics AG Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$22.414
FY2025
5-year range
$22.414 / $32.462
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
#23 of 211
Health Care
What the data says
CRISPR Therapeutics AG's book value per share of $22.414 is higher than 89% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from $4.729 in FY2017 to $42.121 in FY2016.
Based on SEC 10-K filings.
$22.414 in FY2025 with a 5-year CAGR of -3.9%. Top quartile in the Health Care sector.
Declined from $23.981 to $22.414 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
-89.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.9%, indicating a declining trend.
- In FY2025, book value per share decreased 7.1% year-over-year.
- Ranks #23 out of 211 companies in the Health Care sector.
- Peak book value per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.414 | -7.1% |
| FY2024 | $24.138 | +0.7% |
| FY2023 | $23.981 | -1.6% |
| FY2022 | $24.36 | -25.0% |
| FY2021 | $32.462 | +18.6% |
| FY2020 | $27.38 | +51.1% |
| FY2019 | $18.117 | +87.5% |
| FY2018 | $9.662 | +104.3% |
| FY2017 | $4.729 | -88.8% |
| FY2016 | $42.121 | +828.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026